KLK3 and prostate carcinoma: In other words, 26% of subjects with a PSA density ≥0.08 ng/mL/cc truly had clinically significant prostate cancer, and 96% of subjects with a PSA density <0.08 ng/mL/cc truly did not have clinically significant prostate cancer.